Key Financial Data Of Reporting Company

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7726293

Concept As at
2018-02-28
As at
2018-02-28
2017-03-01 to
2018-02-28
2017-03-01 to
2018-02-28
As at
2017-02-28
2016-03-01 to
2017-02-28
2016-03-01 to
2017-02-28
As at
2017-02-28
2015-03-01 to
2016-02-29
As at
2016-02-29
2015-03-01 to
2016-02-29
As at
2016-02-29
2014-03-01 to
2015-02-28
2014-03-01 to
2015-02-28
As at
2015-02-28
As at
2015-02-28
2013-03-01 to
2014-02-28
As at
2014-02-28
As at
2014-02-28
2013-03-01 to
2014-02-28
Key financial data of reporting company
Business results of reporting company
Net sales
112,391,000,000 JPY
147,870,000,000 JPY
145,925,000,000 JPY
112,671,000,000 JPY
161,852,000,000 JPY
119,305,000,000 JPY
119,971,000,000 JPY
156,743,000,000 JPY
150,635,000,000 JPY
123,977,000,000 JPY
Ordinary profit (loss)
21,369,000,000 JPY
28,245,000,000 JPY
28,179,000,000 JPY
22,706,000,000 JPY
28,008,000,000 JPY
26,295,000,000 JPY
27,836,000,000 JPY
28,489,000,000 JPY
28,910,000,000 JPY
29,645,000,000 JPY
Profit (loss)
14,621,000,000 JPY
16,741,000,000 JPY
16,928,000,000 JPY
18,413,000,000 JPY
22,235,000,000 JPY
Share capital
8,473,000,000 JPY
8,473,000,000 JPY
8,473,000,000 JPY
8,473,000,000 JPY
8,473,000,000 JPY
Total number of issued shares
95,164,895 xbrli:shares
95,164,895 xbrli:shares
95,164,895 xbrli:shares
95,164,895 xbrli:shares
95,164,895 xbrli:shares
Net assets
225,687,000,000 JPY
245,227,000,000 JPY
229,205,000,000 JPY
213,374,000,000 JPY
213,422,000,000 JPY
226,095,000,000 JPY
207,107,000,000 JPY
222,054,000,000 JPY
196,308,000,000 JPY
188,860,000,000 JPY
Total assets
264,930,000,000 JPY
299,913,000,000 JPY
278,820,000,000 JPY
248,353,000,000 JPY
251,134,000,000 JPY
284,954,000,000 JPY
247,245,000,000 JPY
285,440,000,000 JPY
251,852,000,000 JPY
223,497,000,000 JPY
Net assets per share
2,693.05
2,912.83
2,724.00
2,547.06
2,518.73
2,657.41
2,416.81
2,580.02
2,281.40
2,203.88
Dividend paid per share
82.00
81.50
81.00
80.00
75.00
Interim dividend paid per share
41.00
40.50
40.00
37.50
35.00
Basic earnings (loss) per share
174.70
228.52
241.27
197.98
208.81
198.71
214.88
219.28
249.30
259.48
Diluted earnings per share
174.57
228.35
241.15
197.88
208.76
198.65
Equity-to-asset ratio
0.851 xbrli:pure
0.813 xbrli:pure
0.817 xbrli:pure
0.858 xbrli:pure
0.849 xbrli:pure
0.790 xbrli:pure
0.838 xbrli:pure
0.774 xbrli:pure
0.776 xbrli:pure
0.845 xbrli:pure
Rate of return on equity
0.067 xbrli:pure
0.081 xbrli:pure
0.090 xbrli:pure
0.079 xbrli:pure
0.080 xbrli:pure
0.081 xbrli:pure
0.093 xbrli:pure
0.090 xbrli:pure
0.118 xbrli:pure
0.125 xbrli:pure
Price-earnings ratio
44.3 xbrli:pure
33.9 xbrli:pure
25.0 xbrli:pure
30.5 xbrli:pure
23.6 xbrli:pure
24.8 xbrli:pure
20.8 xbrli:pure
20.4 xbrli:pure
19.1 xbrli:pure
18.3 xbrli:pure
Payout ratio
0.469 xbrli:pure
0.412 xbrli:pure
0.408 xbrli:pure
0.372 xbrli:pure
0.289 xbrli:pure
Net cash provided by (used in) operating activities
30,453,000,000 JPY
19,910,000,000 JPY
30,923,000,000 JPY
23,232,000,000 JPY
35,845,000,000 JPY
Net cash provided by (used in) investing activities
-1,378,000,000 JPY
1,070,000,000 JPY
-3,912,000,000 JPY
-8,945,000,000 JPY
-5,843,000,000 JPY
Net cash provided by (used in) financing activities
-7,153,000,000 JPY
-18,402,000,000 JPY
-11,616,000,000 JPY
-7,036,000,000 JPY
-6,476,000,000 JPY
Cash and cash equivalents
126,569,000,000 JPY
105,610,000,000 JPY
103,940,000,000 JPY
88,614,000,000 JPY
77,780,000,000 JPY
Number of employees
1,595 xbrli:pure
2,823 xbrli:pure
2,751 xbrli:pure
1,581 xbrli:pure
1,580 xbrli:pure
2,900 xbrli:pure
1,548 xbrli:pure
2,942 xbrli:pure
2,949 xbrli:pure
1,528 xbrli:pure
Average number of temporary employees
318 xbrli:pure
899 xbrli:pure
630 xbrli:pure
329 xbrli:pure
310 xbrli:pure
583 xbrli:pure
311 xbrli:pure
626 xbrli:pure
625 xbrli:pure
330 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.